Oorja Bio
Biopharmaceutical company focused on developing therapies for cardiopulmonary and fibrotic disorders that target underlying disease biology to promote cellular repair and tissue remodeling. Operates R&D and clinical development activities with leadership experience in clinical program execution, regulatory strategy, and commercial partnerships. Locations include Houston and Boston.
Industries
N/A
Nr. of Employees
small (1-50)
Oorja Bio
Texas Medical Center, 2450 Holcombe Blvd | Suite 1.320 | Houston, TX 77021
Services
End-to-end development of novel therapeutics addressing underlying disease biology to promote repair and remodeling of fibrotic tissue.
End-to-end development of novel therapeutics addressing underlying disease biology to promote repair and remodeling of fibrotic tissue.
Expertise Areas
- Cardiopulmonary disease therapeutics
- Fibrotic disease drug development
- Clinical trial management
- Regulatory strategy and submissions
Key Technologies
- Translational therapeutic development targeting fibrotic mechanisms
- Clinical trial design and execution
- Regulatory submission frameworks (BLA, orphan and expedited pathways)
- Pharmacovigilance and clinical safety monitoring